A section of Journal of Clinical Medicine (ISSN 2077-0383).

Section Information

Of all the medical disciplines, medical psychiatry has shown the fastest evolution in terms of knowledge, intervention methodologies and therapeutic results. Some topics have been expanded and are being updated appropriately. This field is a compelling daily focus of interest, largely due to issues connected with ‘brain and behavior’ and ‘biological therapies’. Much space has been devoted to the psychiatry of the early life stages, highlighting the close continuity between this and the psychiatric disorders of adulthood. For example, the Attention-Deficit/Hyperactivity Disorder (ADHD), for as long as the subject is still a child, is distinguished by excessive inattention, hyperactivity, and impulsivity; executive dysfunction; and emotional dysregulation, including inadequate self-control, lack of motivation, and functional impairment. This disorder is now being observed and treated in young adults whether there is concomitant substance use or not.

In the field of medical psychiatry, its connection with aspects of general medicine, once completely ignored, now seems to be of increasing importance. We can cite the relationships between psychiatric diseases and autoimmune diseases, the psychiatric components of physical illnesses such as obesity, the role of impulsivity in bodily diseases, the relationship between psychiatric pathologies and metabolic ones, and the long-term effects of pharmacological treatments and their impact on quality of life and life expectancy.

Another rapidly expanding chapter is that of pharmacotherapy, in which the old and outdated categorical classification that listed anxiolytics, antidepressants, antipsychotics, and mood stabilizers should be abandoned, while the properties of individual molecules should be accurately described instead.

Of particular interest, given their rapid development, are the clinical treatment of and overall response to the substance use disorder and its relationship with other psychiatric diseases (dual disorders). In other words, greater attention should be dedicated to psychiatric comorbidity, which certainly exists in substance use disorders and which leads to clinical pictures that are hard to interpret diagnostically and therapeutically.

We sincerely look forward to receiving your submission to Journal of Clinical Medicine, section of Psychiatry. Our readers are waiting for your contribution to the field of medical psychiatry.

Subject Areas

  • Behavioral addictions
  • Emotional and behavioral disorders in adolescents
  • A-ADHD and its treatment
  • Non-drug biological treatments: changes in diet and exercise, transcranial magnetic stimulation, electroconvulsive therapy
  • Emotional dysregulation in psychiatry
  • Psychiatric components of pain
  • Pain and addiction
  • Psychiatric components of physical illness
  • Impulsivity and metabolic diseases (diabetes, obesity)
  • Mental illnesses and metabolic pathologies
  • Neurodevelopment and physical illnesses (physical health)
  • Neurodevelopment and its impact on quality of life and life expectancy
  • Long-term treatments with antidepressants, antipsychotics, and benzodiazepines, together with their impact on quality of life and life expectancy
  • Autoimmunity and psychiatry
  • Dual disorder clinical presentations
  • Dual disorder treatment
  • Others

Papers Published

Back to TopTop